Honduras

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

CDC DIVISION OF GLOBAL HIV & TB COUNTRY PROFILE

STRATEGIC FOCUS Key Country Leadership


Since 2003, the U.S. Centers for Disease Control and Prevention (CDC) Central American Regional Office
President:
has collaborated with Ministries of Health to respond to the HIV epidemic in the region, including Xiomara Castro
Honduras. CDC supports countries in Central America to achieve the Joint United Nations Program on
HIV/AIDS (UNAIDS) 95-95-95 targets by 2030: 95 percent of people living with HIV (PLHIV) will know their Minister of Health:
José Manuel Matheu
HIV status; 95 percent of people who know their status will receive sustained antiretroviral therapy (ART);
and 95 percent of people receiving ART will have viral suppression. U.S. Ambassador:
Laura Dogu
In partnership with governments, civil society, and other key stakeholders, CDC prioritizes interventions
directly impacting the quality of services for PLHIV and key populations at elevated risk of infection. CDC CDC/DGHT Regional Director:
supports the scale-up of evidence-based programs to bridge gaps around HIV prevention, active case Janell Wright
finding, early ART initiation, optimized treatment services, and achievement of viral load suppression
with a targeted approach to strengthen systems essential to HIV epidemic control. Country Quick Facts
(worldbank.org/en/where-we-
KEY ACTIVITIES AND ACCOMPLISHMENTS work)
Prevent new infections among key populations at elevated risk of infection Per Capita GNI:
$2,740 (2022)
CDC supports the implementation of sexually transmitted infection (STI) surveillance, prevention, and
control strategy, known as VICITS, by its Spanish acronym. VICITS provides a tailored HIV prevention and Population (millions):
testing service package to men who have sex with men, transgender women, and sex workers. This 10.43 (2022)
package includes risk-based counseling, enhanced STI diagnosis and treatment, condom and lubricant Under 5 Mortality:
distribution, HIV testing, peer navigation for linkage to treatment, and a surveillance information system. 16.6/1,000 live births (2021)
CDC contributed to the recent addition of pre-exposure prophylaxis (PrEP) as part of the VICITS package.
Life Expectancy:
70 years (2021)
Increase knowledge of HIV status through active case-finding strategies
CDC improves access to HIV testing among undiagnosed PLHIV by supporting active case-finding plans in Global HIV/AIDS Epidemic
CDC-supported departments. These include testing as part of outreach strategies for key populations, (aidsinfo.unaids.org)
index testing services (identifying current and former partners and household members of PLHIV),
optimized provider-initiated testing, and community testing focusing on men. CDC launched recent HIV Estimated HIV Prevalence
(Ages 15-49): 0.2% (2022)
infection surveillance to identify areas of active transmission (i.e., PLHIV infected in the past 12 months)
to guide prevention and case-finding strategies at the public health level. Estimated AIDS Deaths
(Age ≥15): <500 (2022)
Improve linkage to treatment, ART initiation, advance HIV disease management among PLHIV
Estimated Orphans Due to
CDC supports the provision of a comprehensive treatment package that includes Track and Trace Pre- AIDS: 15,000 (2022)
ART to strengthen the linkage of newly diagnosed PLHIV from the community and non-governmental Reported Number Receiving
organization health centers to ART clinics, rapid ART initiation, diagnosis, and management of HIV Antiretroviral Therapy (ART)
advanced disease opportunistic infections, intensified adherence counseling, and follow up of HIV (Age ≥15): 12,794 (2022)
patients. CDC advocates for optimized treatment regimens and the introduction of differentiated service
delivery models such as pharmacy fast-track refills, multi-month prescriptions, and high viral load Global Tuberculosis
tracking and management. (TB) Epidemic
(who.int/tb/country/data/
Strengthen treatment retention, sustainable viral load suppression among PLHIV profiles/en)

CDC supports retention and re-engagement of PLHIV who are not in care or not virally suppressed and Estimated TB Incidence:
33/100,000 population (2021)
evaluates specimen referral, equipment, information, quality management systems, technology, and
coverage of viral load networks. CDC works closely with Ministries of Health to build local capacity to TB Patients with Known HIV-
perform periodic evaluations and ensure high-quality standards in the viral load process. CDC supports Status who are HIV-Positive:
5.7% (2021)
the HIV National Reference Laboratory to get viral load accredited by the International Organization for
Standardization (ISO) 15189 for medical laboratories. TB Treatment Success Rate:
87% (2020)
Increase the capacity of healthcare systems and the health workforce to serve PLHIV
CDC introduced the Extension for Community Healthcare Outcomes (ECHO) model. This innovative tele-
mentoring initiative uses a hub-and-spoke knowledge-sharing approach where expert teams lead virtual DGHT Country Staff: 1
clinics, amplifying the capacity for providers to deliver best-in-practice care to the underserved in their Locally Employed Staff: 1
communities. Through ECHO, CDC has created virtual communities of practice in HIV prevention, Direct Hires: 0
treatment, mental health, and strategic information. Additionally, CDC launched the Continuous Quality Fellows & Contractors: 0
Improvement Training Initiative. Participants learned how to apply concepts of quality improvement in
the clinical setting to improve service quality. CDC also established the HIV Rapid Test Continuous Quality
Improvement Initiative and conducts economic evaluations to ensure optimal use of funding for
programs that deliver the greatest benefits to people living with HIV, key populations, and Ministries of
Health.
Our success is built on the backbone of science and strong partnerships.
September 2023 | The CDC Division of Global HIV & TB activities are implemented as part of the U.S. President’s Emergency
Plan for AIDS Relief (PEPFAR); non-HIV related TB activities are supported by non-PEPFAR funding.

You might also like